The Predictive Power of Layering Insights and Analytics Set to Transform the Life Sciences Industry
Waltham, MA, July 15, 2024 — Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces the appointment of Aparna Deshpande to Senior Partner and Head of Analytics & Insights. Ms. Deshpande had previously been Senior Partner and Head of Insights for the Company. The added responsibility of leading the Analytics business represents the overall benefits that life science…
Read Now
Trinity Life Sciences Investigates Diversity in Clinical Trials as Stakeholders Prepare for FDA Guidance to Become Final
Waltham, MA, June 25, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, release research on clinical trial diversity with a focus on racial and ethnic minorities in a new white paper, titled Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance. The paper outlines initiatives that are being undertaken at…
Read Now
AbbVie, Astellas Pharma Inc., AstraZeneca, Incyte, Eli Lilly and Company and Novo Nordisk Teams Take Home Trophies for Operational Excellence
Waltham, MA, May 29, 2024 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, announced the winners of the TGaS Advisors Best of Benchmark (BoBs) Awards. The Awards, which are given annually for operational excellence within the pharmaceutical industry, were presented to teams at AbbVie, Astellas Pharma Inc., AstraZeneca, Incyte, Eli Lilly and Company and Novo Nordisk.…
Read Now
Trinity Real Insights is Now Available
Waltham, MA, May 1, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched a new solution that accurately predicts stakeholder behavior providing deeper insights. For the first time, life sciences companies can incorporate real-world, healthcare professional (HCP)-specific prescribing behaviors with primary market research (PMR). This integration provides a view of what physicians are currently doing that is independent of what those physicians may say in market research studies.…
Read Now
“Picking Winners: Portfolio Management for a New Era” White Paper Now Available
Waltham, MA, April 3, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, unveils its Industry Impact Series—a thought leadership series designed to identify key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The first installment of the series, a white paper entitled Picking Winners: Portfolio Management for a New Era, explores the challenges biopharma companies face in selecting…
Read Now
“Annual State of Global Market Access” White Paper Now Available
An Upcoming Webinar Entitled “Annual State of Global Market Access” Will Review Findings
Waltham, MA, March 26, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Annual State of Global Market Access white paper, an evaluation of six key global market access trends that life sciences companies need to be monitoring in 2024 and beyond. The paper explores the consequences of new therapeutic…
Read Now
New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research
Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep technical knowledge and expertise in the nuances of life sciences research, it allows insights and analytics teams to answer brand questions…
Read Now
“Trinity Annual Drug Index” White Paper Now Available
An Upcoming Webinar Entitled “Learn From the Past – Launch Better Tomorrow” Will Review Findings
Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs approved in 2020. An upcoming webinar Learn From the Past – Launch Better Tomorrow will help…
Read Now
New White Paper “2022 NRDL Pricing Implementation and Access Outcomes in China” Available Now from Trinity Life Sciences
Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement Drug List (NRDL) demonstrates promising pricing and access opportunities for innovative drugs with significant clinical benefit. The new white paper “2022 NRDL Pricing Implementation and Access Outcomes in China” provides an in-depth analysis and key takeaways of the update.…
Read Now
COE Provides Deep Strategic Expertise and Analytical Capabilities to Support Cell and Gene Therapy Organizations Across the Value Chain
New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer Cell Therapy Space
Waltham, MA, December 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C>) Center of Excellence (COE) that supports life sciences companies in successfully commercializing…
Read Now
